Alexion Pharmaceuticals, Inc.

Crossmark Global Holdings, Inc. ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

7/21/2021

Shares

15,190

Value ($000)

2,791

Weight

0.1%

2019 Q4 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	7/21/2021	2,791	0.1%	15,190	6/30/2021
2021 Q1	4/15/2021	2,278	0.1%	14,897	3/31/2021
2020 Q4	1/14/2021	2,473	0.1%	15,827	12/31/2020
2020 Q3	10/8/2020	1,976	0.1%	17,265	9/30/2020
2020 Q2	8/14/2020	1,949	0.1%	17,369	6/30/2020
2020 Q1	4/28/2020	1,507	0.1%	16,779	3/31/2020
2019 Q4	2/6/2020	1,716	0.0%	15,866	12/31/2019